THE PENETRATION OF AMINOGLYCOSIDES INTO THE ALVEOLAR LINING FLUID OF RATS - THE EFFECT OF AIRWAY INFLAMMATION

被引:20
作者
VALCKE, Y
PAUWELS, R
VANDERSTRAETEN, M
机构
[1] Respiratory Diseases Dept., University Hospital, B9000 Ghent
来源
AMERICAN REVIEW OF RESPIRATORY DISEASE | 1990年 / 142卷 / 05期
关键词
D O I
10.1164/ajrccm/142.5.1099
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
The concentration-time profile of gentamicin and tobramycin in the alveolar lining fluid (ALF) of rats was determined after intravenous bolus injection using bronchoalveolar lavage (BAL). BAL can be used for evaluating the penetration of both aminoglycosides into the ALF if highly sensitive detection methods are used, and an endogenous marker (urea) can be applied to avoid the unpredictable dilutional effect of the lavage procedure. The concentration of gentamicin and tobramycin in ALF reached a peak after 5 and 10 min, respectively, and remained high when plasma concentrations were declining, suggesting an accumulation reservoir in the lung acini. The ratio of the AUC of the concentration-time profile in ALF and plasma was 0.67 and 0.45 for gentamicin and tobramycin, respectively. The penetration of both aminoglycosides into the ALF was significantly higher after induction of airway inflammation by inhalation of endotoxin. The ratio of the AUC in ALF and plasma in the endotoxin-exposed animals was 0.76 and 0.55 for gentamicin and tobramycin, respectively. The ratio of the AUC of the concentration-time profile of gentamicin in ALF to that of tobramycin was 1.27 without inflammation and 1.44 after endotoxin exposure. Thus, both with and without inflammation, gentamicin penetrates better into the ALF than does tobramycin.
引用
收藏
页码:1099 / 1103
页数:5
相关论文
共 48 条
[1]   CONCENTRATION OF TOBRAMYCIN IN BRONCHIAL-SECRETIONS [J].
ALEXANDER, MR ;
BERGLUND, EM ;
KASIK, JE ;
FOX, A ;
CHINN, WM .
CHEST, 1979, 75 (06) :675-678
[2]  
ALEXANDER MR, 1982, AM REV RESPIR DIS, V125, P208
[3]   GENERAL-PRINCIPLES OF ANTIBIOTIC TISSUE PENETRATION [J].
BARZA, M ;
CUCHURAL, G .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1985, 15 :59-75
[4]   TISSUE PENETRATION OF ANTIBIOTICS [J].
BERGERON, MG .
CLINICAL BIOCHEMISTRY, 1986, 19 (02) :90-100
[5]  
BERGOGNEBEREZIN E, 1988, RESPIRATORY INFECTIO, P608
[6]  
BLECKA LJ, 1983, AM ASS CLIN CHEM MAR, P1
[7]   PULMONARY DISPOSITION OF MOXALACTAM [J].
BRAUDE, AC ;
COHEN, RD ;
PENNER, JL ;
PRESTON, MA ;
REBUCK, AS .
CHEST, 1984, 86 (06) :881-883
[8]   PULMONARY DISPOSITION OF CORTISOL [J].
BRAUDE, AC ;
REBUCK, AS .
ANNALS OF INTERNAL MEDICINE, 1982, 97 (01) :59-60
[9]   PULMONARY DISPOSITION OF TOBRAMYCIN [J].
BRAUDE, AC ;
HORNSTEIN, A ;
KLEIN, M ;
VAS, S ;
REBUCK, AS .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1983, 127 (05) :563-565
[10]  
DELACROIX DL, 1985, AM REV RESPIR DIS, V132, P829